The Malaysian healthcare industry has been robust in recent years. However, the CORONA VIRUS that grips all business sectors has also disrupt the healthcare industry. Immediate interventions need to be taken. Being the top player in ASEAN and a home to many multinationals and local pharma and medical device manufacturers, Malaysia surely has its own strategy to pivot during this trying time. This webinar brought together subject matter experts from the government and private sector to shed light on the impact of Covid-19 on policy & regulations, risk management for foreign pharmaceutical products & medical devices in the country and opportunities for UK businesses.
Watch the webinar replay here: